Co-Diagnostics
CODX
7 hedge funds and large institutions have $812K invested in Co-Diagnostics in 2018 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 3 closing their positions.
139% more capital invested
Capital invested by funds: $340K → $812K (+$472K)
0.01% more ownership
Funds ownership: 0.04% → 0.06% (+0.01%)
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
13% less funds holding
Funds holding: 8 → 7 (-1)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$131K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$130K |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$571 |
| 4 |
Morgan Stanley
New York
|
+$571 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HighTower Advisors
Chicago,
Illinois
|
-$58.4K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$33K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$7.18K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$5K |
| 5 |
BlackRock
New York
|
-$3K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Vanguard Group
Malvern,
Pennsylvania
| $312K | +$130K | +1,591 | +147% |
|
|
2
HighTower Advisors
Chicago,
Illinois
| $301K | -$58.4K | -716 | -22% |
|
|
3
Geode Capital Management
Boston,
Massachusetts
| $187K | +$131K | +1,610 | New |
|
|
4
UBS Group
Zurich,
Switzerland
| $9K | -$7.18K | -88 | -54% |
|
|
LTFS
5
Ladenburg Thalmann Financial Services
Miami,
Florida
| $1K | – | – | – |
|
|
6
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $1K | +$571 | +7 | New |
|
|
7
Morgan Stanley
New York
| $1K | +$571 | +7 | +350% |
|
|
8
Citadel Advisors
Miami,
Florida
| – | -$33K | -499 | Closed |
|
|
TRCT
9
Tower Research Capital (TRC)
New York
| – | -$5K | -72 | Closed |
|
|
10
BlackRock
New York
| – | -$3K | -43 | Closed |
|
CODX Hedge Fund Activity: Q2 2018 in Review
7 of the 4,369 institutional investors tracked by Wall St. Rank reported a position in Co-Diagnostics (CODX) for Q2 2018, worth a combined $812K — up 139% from $340K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of CODX and 2 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 2 added.
The largest buyer was Geode Capital Management, opening a new position worth an estimated $131K. The largest seller was HighTower Advisors, cutting an estimated $58.4K.
- 7 institutional investors held Co-Diagnostics (CODX) as of Q2 2018, down from 8 in Q1 2018.
- Funds reported $812K of Co-Diagnostics stock for Q2 2018, up 139% quarter-over-quarter.
- 2 funds opened new Co-Diagnostics positions in Q2 2018 and 3 closed out, a net change of -1 holder.
- The largest Co-Diagnostics buyer in Q2 2018 was Geode Capital Management, an estimated $131K added.
- The largest Co-Diagnostics seller in Q2 2018 was HighTower Advisors, an estimated $58.4K sold.
Based on aggregated 13F filings for Q2 2018.